NRx Pharmaceuticals (NRXP) Set to Announce Earnings on Tuesday

NRx Pharmaceuticals (NASDAQ:NRXP) will announce its earnings results after the market closes on Tuesday, May 14th.

NRx Pharmaceuticals (NASDAQ:NRXP) last released its quarterly earnings results on Friday, March 29th. The company reported ($0.50) earnings per share (EPS) for the quarter.

NRx Pharmaceuticals Stock Down 2.8 %

NASDAQ:NRXP traded down $0.08 during trading hours on Wednesday, hitting $2.73. 99,821 shares of the company traded hands, compared to its average volume of 308,214. The company has a market cap of $28.83 million, a PE ratio of -0.70 and a beta of 1.15. The firm’s 50-day simple moving average is $26.62 and its 200-day simple moving average is $34.35. NRx Pharmaceuticals has a one year low of $1.90 and a one year high of $12.00.

NRx Pharmaceuticals Company Profile

NRx Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned FDA-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior.